UK launches Rapid-Fire trial to test new wave of COVID drugs
NCT ID NCT04746183
Summary
This UK-based trial is a flexible testing platform designed to quickly evaluate several potential new treatments for COVID-19 in adults. It will test different drugs and doses to find the safest and most effective options for both mild and severe cases. The goal is to identify promising treatments that can then move into larger, final-stage trials.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID19 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Desmond Tutu Health Foundation
COMPLETEDCape Town, South Africa
-
Ezintsha
COMPLETEDJohannesburg, South Africa
-
Kings College Hospital NHS Foundation Trust
ACTIVE_NOT_RECRUITINGLondon, United Kingdom
-
Liverpool University Hospitals NHS Foundation Trust
RECRUITINGLiverpool, L7 8XP, United Kingdom
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-••••
Contact
Contact
Contact
-
Manchester University NHS Foundation Trust
ACTIVE_NOT_RECRUITINGManchester, United Kingdom
-
University Hospital Southampton NHS Foundation Trust
ACTIVE_NOT_RECRUITINGSouthampton, SO16 6YD, United Kingdom
Conditions
Explore the condition pages connected to this study.